133 related articles for article (PubMed ID: 10212169)
21. Contrasting effects of blockade of nitric oxide formation on resistance and conductance coronary vessels in conscious dogs.
Parent R; Hamdad N; Ming Z; Lavallée M
Cardiovasc Res; 1996 Apr; 31(4):555-67. PubMed ID: 8689647
[TBL] [Abstract][Full Text] [Related]
22. L-arginine improves endothelium-dependent relaxation of conductance and resistance coronary arteries in coronary artery disease.
Dubois-Randé JL; Zelinsky R; Chabrier PE; Castaigne A; Geschwind H; Adnot S
J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S211-3. PubMed ID: 1282973
[TBL] [Abstract][Full Text] [Related]
23. Tetrahydrobiopterin improves endothelial function in patients with coronary artery disease.
Maier W; Cosentino F; Lütolf RB; Fleisch M; Seiler C; Hess OM; Meier B; Lüscher TF
J Cardiovasc Pharmacol; 2000 Feb; 35(2):173-8. PubMed ID: 10672847
[TBL] [Abstract][Full Text] [Related]
24. Vasomotor responses of coronary stenoses to acetylcholine and their relation to serum lipid levels in stable angina pectoris.
Tousoulis D; Gorog D; Crake T; Homaei H; Ahmed N; Davies GJ
Am J Cardiol; 1999 Jun; 83(12):1606-10. PubMed ID: 10392862
[TBL] [Abstract][Full Text] [Related]
25. Effects of calcitonin gene-related peptide on normal and atheromatous vessels and on resistance vessels in the coronary circulation in humans.
Ludman PF; Maseri A; Clark P; Davies GJ
Circulation; 1991 Nov; 84(5):1993-2000. PubMed ID: 1934374
[TBL] [Abstract][Full Text] [Related]
26. L-arginine preferentially dilates stenotic segments of coronary arteries thereby increasing coronary flow.
Lauer T; Kleinbongard P; Rath J; Schulz R; Kelm M; Rassaf T
J Intern Med; 2008 Sep; 264(3):237-44. PubMed ID: 18341529
[TBL] [Abstract][Full Text] [Related]
27. Exogenous hyaluronidase induces release of nitric oxide from the coronary endothelium.
Evora PR; Pearson PJ; Chua YL; Discigil B; Schaff HV
J Thorac Cardiovasc Surg; 2000 Oct; 120(4):707-11. PubMed ID: 11003752
[TBL] [Abstract][Full Text] [Related]
28. Magnesium causes nitric oxide independent coronary artery vasodilation in humans.
Teragawa H; Kato M; Yamagata T; Matsuura H; Kajiyama G
Heart; 2001 Aug; 86(2):212-6. PubMed ID: 11454846
[TBL] [Abstract][Full Text] [Related]
29. Substance P dilates epicardial coronary arteries and increases coronary blood flow in humans.
Crossman DC; Larkin SW; Fuller RW; Davies GJ; Maseri A
Circulation; 1989 Sep; 80(3):475-84. PubMed ID: 2475277
[TBL] [Abstract][Full Text] [Related]
30. Acute effects of celiprolol on angiographically normal and stenotic coronary arteries.
Jost S; Hausmann D; Lippolt P; Sturm M
Cardiovasc Drugs Ther; 1997 Apr; 11(2):133-8. PubMed ID: 9140690
[TBL] [Abstract][Full Text] [Related]
31. Variable coronary vasomotor responses to acetylcholine in patients with normal coronary arteriograms: evidence for localised endothelial dysfunction.
Tousoulis D; Davies G; Lefroy DC; Haider AW; Crake T
Heart; 1996 Mar; 75(3):261-6. PubMed ID: 8800989
[TBL] [Abstract][Full Text] [Related]
32. Myocardial contractile effects of L-arginine in the human allograft.
Paulus WJ; Kästner S; Vanderheyden M; Shah AM; Drexler H
J Am Coll Cardiol; 1997 May; 29(6):1332-8. PubMed ID: 9137232
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of nitric oxide synthesis during the cold pressor test in patients with coronary artery disease.
Tousoulis D; Davies G; Tentolouris C; Crake T; Toutouzas P
Am J Cardiol; 1997 Jun; 79(12):1676-9. PubMed ID: 9202363
[TBL] [Abstract][Full Text] [Related]
34. Coronary angioplasty ameliorates hypoperfusion-induced endothelial dysfunction in patients with stable angina pectoris.
Komaru T; Isoyama S; Sekiguchi N; Akai K; Shiba N; Yasuda S; Funakoshi M; Shirato K; Zuguchi M; Nozaki E; Nishioka O; Tamaki K
J Am Coll Cardiol; 1996 Jan; 27(1):30-7. PubMed ID: 8522707
[TBL] [Abstract][Full Text] [Related]
35. Diffuse disorder of coronary artery vasomotility in patients with coronary spastic angina. Hyperreactivity to the constrictor effects of acetylcholine and the dilator effects of nitroglycerin.
Okumura K; Yasue H; Matsuyama K; Ogawa H; Kugiyama K; Ishizaka H; Sumida H; Fujii H; Matsunaga T; Tsunoda R
J Am Coll Cardiol; 1996 Jan; 27(1):45-52. PubMed ID: 8522709
[TBL] [Abstract][Full Text] [Related]
36. Bradykinin induced dilatation of human epicardial and resistance coronary arteries in vivo: effect of inhibition of nitric oxide synthesis.
Kato M; Shiode N; Yamagata T; Matsuura H; Kajiyama G
Heart; 1997 Nov; 78(5):493-8. PubMed ID: 9415011
[TBL] [Abstract][Full Text] [Related]
37. Augmented vasodilator response to L-arginine after coronary angioplasty may attenuate restenosis.
Fukumoto Y; Urabe Y; Kubo T; Kaku T; Egashira K; Shimokawa H; Takeshita A
Heart Vessels; 2002 Jul; 16(5):171-4. PubMed ID: 12181589
[TBL] [Abstract][Full Text] [Related]
38. Patterns of coronary artery stenosis vasomotion: observed versus "predicted" stenosis reactivity in patients with chronic stable angina.
Tousoulis D; McFadden E; Kaski JC
Coron Artery Dis; 1993 Jun; 4(6):529-36. PubMed ID: 8261231
[TBL] [Abstract][Full Text] [Related]
39. Substance P for evaluation of coronary endothelial function after cardiac transplantation.
Kushwaha SS; Crossman DC; Bustami M; Davies GJ; Mitchell AG; Maseri A; Yacoub MH
J Am Coll Cardiol; 1991 Jun; 17(7):1537-44. PubMed ID: 1709653
[TBL] [Abstract][Full Text] [Related]
40. The LargPAD Trial: Phase IIA evaluation of l-arginine infusion in patients with peripheral arterial disease.
Kashyap VS; Lakin RO; Campos P; Allemang M; Kim A; Sarac TP; Hausladen A; Stamler JS
J Vasc Surg; 2017 Jul; 66(1):187-194. PubMed ID: 28366306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
